Julie Johnson sold Amdocs Ltd (NASDAQ: DOX)
Julie Johnson (D-TX), a U.S. Representative, has disclosed 1 trade in Amdocs Ltd (DOX) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Julie Johnson sold $1,001 - $15,000 of Amdocs Ltd (NASDAQ: DOX) on February 11, 2025. Since that trade, DOX is down -31.94% against the S&P 500 up +22.26%, an outperformance of -54.20%.
Data updated
Julie Johnson's DOX trades vs the price
DOX is down -31.94% since Julie Johnson sold on February 11, 2025, versus +22.26% for the S&P 500.
Performance since this trade
All Julie Johnson DOX trades
Julie Johnson & DOX trading FAQ
Is it legal for Julie Johnson to trade Amdocs Ltd (DOX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Amdocs Ltd (DOX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Julie Johnson sell DOX?
Julie Johnson disclosed a sale of $1,001 - $15,000 of Amdocs Ltd (DOX) on February 11, 2025, according to public STOCK Act filings.
How has DOX performed since Julie Johnson's trade?
Since Julie Johnson sold DOX on February 11, 2025, the stock is down -31.94%, versus +22.26% for the S&P 500 over the same period, an outperformance of -54.20%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional DOX trades?
Quantellect tracks every disclosed congressional trade in Amdocs Ltd (DOX) on the Amdocs Ltd congressional trading page, which aggregates filings across all members of Congress.
Julie Johnson's DOX tradesAll congressional filings for Amdocs LtdJulie Johnson's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.